Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Azomycin riboside: a new radiosensitizer

J E Pedersen, G Barron, J D Chapman

    International Journal of Radiation Oncology, Biology, Physics
    |March 1, 1982
    PubMed
    Summary

    Azomycin riboside (AR) shows promise as a hypoxic cell radiosensitizer in vitro, matching or exceeding misonidazole (MISO). However, in vivo studies reveal AR is less effective and potentially as toxic as MISO.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

    Physical review letters·2026
    Same author

    Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

    Physical review letters·2025
    Same author

    Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

    Physical review letters·2025
    Same author

    Effect of prepartum dietary cation-anion difference strategy and level of dietary calcium on postpartum blood calcium status and milk production of multiparous Holstein cows.

    Journal of dairy science·2025
    Same author

    Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

    Physical review letters·2025
    Same author

    Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

    Physical review letters·2025

    Area of Science:

    • Oncology
    • Radiotherapy
    • Pharmacology

    Background:

    • Hypoxic tumor cells are resistant to radiation therapy.
    • Radiosensitizers enhance the efficacy of radiation in treating hypoxic tumors.

    Purpose of the Study:

    • To evaluate azomycin riboside (AR) as a potential radiosensitizer for hypoxic cells.
    • To compare the efficacy and toxicity of AR with misonidazole (MISO).

    Main Methods:

    • In vitro assessment of AR's radiosensitizing and cytotoxic effects on hypoxic cells.
    • In vivo evaluation using tumor regrowth delay assays.
    • Host toxicity assessment via LD50 assays.

    Main Results:

    • AR demonstrated comparable or superior in vitro radiosensitization and direct cytotoxicity against hypoxic cells compared to MISO.
    • In vivo, AR was less effective than MISO in delaying tumor regrowth.
    • AR exhibited host toxicity levels similar to MISO.

    Conclusions:

    • AR shows potential as an in vitro radiosensitizer but lacks in vivo efficacy advantage over MISO.
    • Further research is needed to determine if AR offers clinical benefits, potentially through reduced toxicity or targeted delivery.

    Related Experiment Videos